Estrogens as antioxidants - reducing heart disease in younger postmenopausal women
HRT could be used to protect younger postmenopausal women from heart disease. An article published in the journal Lipids in Health and Disease shows that estrogens commonly used in HRT reduce the build up of harmful oxidised lipoproteins, which can lead to heart disease, by acting as antioxidants.
It is well known that high-density lipoproteins (HDL) protect against heart disease while low-density lipoproteins (LDL) promote it. However, recent research has shown that the relationship is not that simple. The effectiveness of both types of lipoprotein change when they are oxidised by free radicals – highly reactive by-products of metabolism. If LDL becomes oxidised its ability to cause heart disease increases. If HDL becomes oxidised its ability to protect against heart disease is lessened.
Researchers from St. Michael’s Hospital, part of the University of Toronto, have shown that estrogens can act as antioxidants, which neutralise free radicals, and hence protect HDL from oxidation. In addition, high levels of HDL are able to protect LDL from oxidation, and this ability is strongly enhanced when estrogens are present.
Dr Bhagu Bhavnani’s team, who carried out the research, write, “The inhibition of HDL oxidation and the enhancement provided by estrogens toward the inhibition of LDL oxidation may be another way in which estrogens reduce the risk of coronary heart disease in healthy young postmenopausal women.”
Although recent randomised control trials have shown that HRT in older women may not reduce the incidence of coronary heart disease, Dr. Bhavnani believes that this is not the whole story. Although his team carried out experiments in test tubes rather than in human subjects they saw that estrogen had beneficial effects at concentrations lower than those found in women on HRT. He urges that, “randomised control trials using lower doses of HRT, different estrogens and progestins, and in younger postmenopausal women, from 50 to 60 years, are urgently needed to resolve the confusion created by recent studies”.
The research team used blood taken from men and postmenopausal women to carry out experiments in vitro. They measured the resistance of HDL to oxidation in the presence or absence of increasing concentrations of eleven different estrogens. All of these estrogens are components of a combined estrogen supplement that is commonly used for HRT by postmenopausal women. They then assessed whether the presence of HDL increased the resistance of LDL to oxidation, and if this resistance was further enhanced by the addition of estrogen.
They found that all the estrogens tested were able to protect HDL from oxidation and to enhance HDL’s ability to protect LDL from oxidation. They also found that different estrogens had different potencies as antioxidants, with an estrogen called Equilenin being the most effective.
According to recent data from the British Heart Foundation, women are five times less likely to suffer from coronary heart disease than men. This reduced risk can only partly be explained by differences in behaviour, such as smoking or stress levels. As women’s risk of heart disease increases after menopause it has been suggested that ovarian hormones such as estrogen play a role in protecting younger women from the disease. The research from Bhavnani’s team supports this idea.
Gemma Bradley | BioMed Central
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Mapping the interaction of a single atom with a single photon may inform design of quantum devices
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...